123 Results

People

  1. Moore
    Moore
  2. Norton
    Norton
  3. Gabrilove
    Gabrilove
  4. Spriggs
    Spriggs
  5. Reich
    Reich
  6. Seidman
    Seidman
  7. Yao
    Yao
  8. Hudis
    Hudis
  9. Welte
    Welte
  10. Crown
    Crown

Groups

  1. Department of Medicine (62)
  2. Sloan Kettering Institute Faculty (38)
  3. Solid Tumor Oncology Division (36)
  4. Hematologic Malignancies, Division of (30)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)
  6. Cell Biology Program Faculty (24)
  7. Breast Medicine Service (20)
  8. Survivorship Research (20)
  9. Center for Hematologic Malignancies (19)
  10. Pediatrics, Department of (19)
  1. "granulocyte colony-stimulating factor"
Formats
  1. Journal Article (108)
  2. Conference Paper (8)
  3. Review (3)
  4. Meeting Abstract (2)
  5. Research Letter (2)
Groups
  1. Department of Medicine (62)
  2. Sloan Kettering Institute Faculty (38)
  3. Solid Tumor Oncology Division (36)
  4. Hematologic Malignancies, Division of (30)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)
  6. Cell Biology Program Faculty (24)

More Groups

People
  1. Malcolm Moore (24)
  2. Larry Norton (16)
  3. Janice Gabrilove (13)
  4. David Spriggs (10)
  5. Andrew Seidman (9)
  6. Lilian Reich (9)

More People

Years
  1. 2024 (4)
  2. 2023 (3)
  3. 2021 (2)
  4. 2020 (1)
  5. 2015 (1)
  6. 2014 (1)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Blood (10)
  3. Seminars in Oncology (9)
  4. JNCI: Journal of the National Cancer Institute (6)
  5. Cancer (5)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. Elsevier Inc. (18)
  2. American Society of Clinical Oncology (13)
  3. American Society of Hematology (10)
  4. Oxford University Press (10)
  5. American Association for Cancer Research (8)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection
    Review

    Dietz, L.; Marini, J.; Hashmi, H.; McGann, M.
    Journal of Oncology Pharmacy Practice (2024)

    Fulltext@MSK | Save
  • Immune effector cell-associated haematotoxicity after CAR T-cell therapy: From mechanism to management
    Review

    Rejeski, K.; Jain, M. D.; Shah, N. N.; Perales, M. A.; Subklewe, M.
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia
    Journal Article

    Oved, J. H.; Gibson, N. M.; Venella, K.; Elgarten, C. W.; Wray, L.; Warren, J. T.; Olson, T. S.
    Frontiers in Immunology (2024)

    Fulltext@MSK | Save
  • GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma
    Review

    Mora, J.; Modak, S.; Kinsey, J.; Ragsdale, C. E.; Lazarus, H. M.
    International Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model
    Journal Article

    Hughes, J. H.; Tong, D. M. H.; Burns, V.; Daly, B.; Razavi, P.; Boelens, J. J.; Goswami, S.; Keizer, R. J.
    CPT: Pharmacometrics and Systems Pharmacology (2023)

    Fulltext@MSK | Save
  • Efficacy, safety, and cost of mobilization strategies in multiple myeloma: A prospective, observational study
    Research Letter

    Dhakal, B.; Zhang, M. J.; Burns, L. J.; Tang, X.; Meyer, C.; Mau, L. W.; Nooka, A. K.; Stadtmauer, E.; Micallef, I. N.; McGuirk, J.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Stem cell mobilization yields with daratumumab- and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma: Findings from the MASTER and GRIFFIN trials
    Journal Article

    Chhabra, S.; Callander, N.; Watts, N. L.; Costa, L. J.; Thapa, B.; Kaufman, J. L.; Laubach, J.; Sborov, D. W.; Reeves, B.; Rodriguez, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Planned granulocyte colony-stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with thymoglobulin for myeloid malignancy
    Journal Article

    Orfali, N.; Zhang, M. J.; Allbee-Johnson, M.; Boelens, J. J.; Artz, A. S.; Brunstein, C. G.; McNiece, I. K.; Milano, F.; Abid, M. B.; Chee, L.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Real-world incidence of febrile neutropenia among patients treated with single-agent amrubicin: Necessity of the primary prophylactic administration of granulocyte colony-stimulating factor
    Journal Article

    Dotsu, Y.; Yamaguchi, H.; Fukuda, M.; Suyama, T.; Honda, N.; Umeyama, Y.; Taniguchi, H.; Gyotoku, H.; Takemoto, S.; Tagawa, R.; more...
    Journal of Clinical Medicine (2021)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?
    Research Letter

    Nawar, T.; Morjaria, S.; Kaltsas, A.; Patel, D.; Perez-Johnston, R.; Daniyan, A. F.; Mailankody, S.; Parameswaran, R.
    American Journal of Hematology (2020)

    Fulltext@MSK | Save